Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: 4J THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-09-30 to 2032-03-31
Current total value of award: $37589799.14
Description: THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO EXERCISE OPTION 1 CLIN 0002 TO CONDUCT NON-CLINICAL STUDIES, 2ND NON-GLP TOX; EFFICACY/OFF-TARGET STUDIES AND UPDATE ARTICLE C.1. STATEMENT OF WORK DATED JANUARY 10, 2025. THE OPTION PERIOD OF PERFORMA